Close

Mark Jit

BSc PhD MPH

Professor
of Vaccine Epidemiology

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

Tel.
+44 (0)20 7927 2852

I work mainly at LSHTM, but also hold a visiting professorship at the School of Public Health, University of Hong Kong. I worked for many years at Public Health England (as well as its predecessor the Health Protection Agency), and continue to collaborate with colleagues there.

Affiliations

Department of Infectious Disease Epidemiology

Centres

Centre for the Mathematical Modelling of Infectious Diseases (CMMID)
Vaccine Centre

Teaching

I teach postgraduate and professional courses on vaccinology, modelling and economics of infectious diseases, both at LSHTM and elsewhere. I co-coordinate a module on Health Decision Science at LSHTM, and the Croucher Summer Course on Vaccinology for Public Health and Clinical Practice in the 21st century held in Hong Kong in collaboration with the University of Hong Kong. I also help to coordinate training workshops on modelling and economics of vaccines across Asia.

Students interested in opportunities to conduct epidemiological, economic and/or policy research on vaccines and other infectious disease interventions towards a Masters, PhD or DrPH degree are welcome to get in touch.

Research

At the moment much of my work is focused on understanding the Coronavirus Disease 2019 (COVID-19) pandemic and ways to mitigate it.

In non-pandemic times, my main research focus is investigating the epidemiological and economic impact of vaccines and other infectious disease control interventions to support evidence-based public health decision making. Much of this work uses transmission dynamic models to capture ecological effects of interventions beyond the individual.

I am particularly interested in the use of modelling to inform the interface between technical questions about projecting the impact that vaccines can have, and normative questions about what health and economic goals we should pursue. Examples of such questions include the distribution of the costs and benefits of vaccines across different countries and people around the world, and the value of long-term outcomes such as reducing antimicrobial resistance or eradicating an infection.

I work closely with decision makers such as the World Health Organization, country governments and national immunisation technical advisory groups such as the UK's Joint Committee on Vaccination and Immunisation. In particular, my work has helped inform immunisation policy on a range of vaccines (including measles, HPV, pneumococcal, rotavirus, influenza and dengue vaccines) in both developed and developing countries, in close collaboration with partners based in those countries. More recently, I have been examining the potential health and economic impact of COVID-19 vaccination.

Research Area
Decision analysis
Economic evaluation
Vaccines
Immunisation
Modelling
Discipline
Economics
Mathematical modelling
Vaccinology
Disease and Health Conditions
Diarrhoeal diseases
Infectious disease
Measles
Pandemic diseases
Cervical cancer
Dengue
Human papillomavirus (HPV)
Influenza
Respiratory disease
Sexually transmitted infection
Coronavirus
Country
China
United Kingdom
Hong Kong
Region
East Asia & Pacific (all income levels)
European Union
World

Selected Publications

The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories.
Liu Y; Morgenstern C; Kelly J; Lowe R; CMMID COVID-19 Working Group; Jit M
2021
BMC Medicine
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
Wouters OJ; Shadlen KC; Salcher-Konrad M; Pollard AJ; Larson HJ; Teerawattananon Y; Jit M
2021
Lancet (London, England)
Estimating number of cases and spread of coronavirus disease (COVID-19) using critical care admissions, United Kingdom, February to March 2020.
Jit M; Jombart T; Nightingale ES; Endo A; Abbott S; LSHTM Centre for Mathematical Modelling of Infectious Diseases C; Edmunds WJ
2020
EUROSURVEILLANCE
Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study.
Russell TW; Wu JT; Clifford S; Edmunds WJ; Kucharski AJ; Jit M
2020
LANCET PUBLIC HEALTH
Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis.
Chen C; Cervero Liceras F; Flasche S; Sidharta S; Yoong J; Sundaram N; Jit M
2018
LANCET GLOBAL HEALTH
Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.
Atkins KE; Lafferty EI; Deeny SR; Davies NG; Robotham JV; Jit M
2017
The Lancet infectious diseases
The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.
Flasche S; Jit M; Rodríguez-Barraquer I; Coudeville L; Recker M; Koelle K; Milne G; Hladish TJ; Perkins TA; Cummings DAT
2016
PLoS medicine
Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study.
Jit M; Brisson M; Portnoy A; Hutubessy R
2014
The Lancet Global health
Social contacts and mixing patterns relevant to the spread of infectious diseases.
Mossong J; Hens N; Jit M; Beutels P; Auranen K; Mikolajczyk R; Massari M; Salmaso S; Tomba GS; Wallinga J
2008
PLoS medicine
See more Publications